TP53 and ovarian cancer: Because it is widely accepted that TP53 mutation is a tumor-initiating event in HGS ovarian cancer (Ahmed et al. 2010; The Cancer Genome Atlas Research Network 2011; Bashashati et al. 2013), this mutation was expected to be present in all tumor cells.